Drug recall · January 8, 2025
Dapsone Gel 7.5% recall
Why: Crystallization
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack
- Lots / codes
Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026
- Quantity
- 2760 packs
- Company
- Viona Pharmaceuticals Inc, Cranford, NJ
- Distribution
- US Nationwide
- Initiated
- December 10, 2024 · Voluntary: Firm initiated
- Classified
- January 2, 2025
- Reported
- January 8, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dapsone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.